A Novel Mitochondria-Targeting Iron Chelator Neuroprotects Multimodally via HIF-1 Modulation Against a Mitochondrial Toxin in a Dopaminergic Cell Model of Parkinson’s Disease
暂无分享,去创建一个
J. Elson | F. H. van der Westhuizen | I. Pienaar | S. Gutbier | Olimpo García-Beltrán | Belinda Fouché | Stephanie Turner | Rebecca Gorham | Eloise J Stephenson | Simon Gutbier
[1] C. Pourzand,et al. The synthesis and properties of mitochondrial targeted iron chelators , 2022, BioMetals.
[2] S. Rutella,et al. Hypoxia Signaling in Parkinson’s Disease: There Is Use in Asking “What HIF?” , 2021, Biology.
[3] C. Ríos,et al. Antioxidant Effect of Hydroxytyrosol, Hydroxytyrosol Acetate and Nitrohydroxytyrosol in a Rat MPP+ Model of Parkinson’s Disease , 2021, Neurochemical Research.
[4] D. Song,et al. Dexmedetomidine protects SH‐SY5Y cells against MPP+‐induced declining of mitochondrial membrane potential and cell cycle deficits , 2021, The European journal of neuroscience.
[5] I. Yanatori,et al. Parkinson's disease: Alterations in iron and redox biology as a key to unlock therapeutic strategies , 2021, Redox biology.
[6] Linxi Chen,et al. Mitochondrial iron metabolism and its role in diseases. , 2020, Clinica chimica acta; international journal of clinical chemistry.
[7] I. Yanatori,et al. Iron loss triggers mitophagy through induction of mitochondrial ferritin , 2020, EMBO reports.
[8] Dongfeng Chen,et al. FTH1 Inhibits Ferroptosis Through Ferritinophagy in the 6-OHDA Model of Parkinson’s Disease , 2020, Neurotherapeutics.
[9] J. Elson,et al. Design and evaluation of bi-functional iron chelators for protection of dopaminergic neurons from toxicants , 2020, Archives of Toxicology.
[10] A. Poetsch. The genomics of oxidative DNA damage, repair, and resulting mutagenesis , 2020, Computational and structural biotechnology journal.
[11] F. Salachas,et al. Conservative iron chelation for neurodegenerative diseases such as Parkinson’s disease and amyotrophic lateral sclerosis , 2020, Journal of Neural Transmission.
[12] J. Trojanowski,et al. α-Synuclein pathology in Parkinson’s disease and related α-synucleinopathies , 2019, Neuroscience Letters.
[13] Dongfeng Chen,et al. Moxibustion Exerts a Neuroprotective Effect through Antiferroptosis in Parkinson's Disease , 2019, Evidence-based complementary and alternative medicine : eCAM.
[14] D. Stanković,et al. Use of cyclic voltammetry to determine the antioxidant capacity of berry fruits: correlation with spectrophotometric assays , 2019, European Journal of Horticultural Science.
[15] Guozhen Fang,et al. Intracellular Fenton reaction based on mitochondria-targeted copper(ii)–peptide complex for induced apoptosis , 2019, Journal of Materials Chemistry B.
[16] R. Anjum,et al. Parkinson's disease: Mechanisms, translational models and management strategies , 2019, Life sciences.
[17] D. Turnbull,et al. Mitochondrial Dysfunction in Parkinson’s Disease—Cause or Consequence? , 2019, Biology.
[18] D. Long,et al. HIF-1α protects against oxidative stress by directly targeting mitochondria , 2019, Redox biology.
[19] C. Lim,et al. A 3D microvascular network model to study the impact of hypoxia on the extravasation potential of breast cell lines , 2018, Scientific Reports.
[20] M. Tambuwala,et al. Albumin nano-encapsulation of caffeic acid phenethyl ester and piceatannol potentiated its ability to modulate HIF and NF-kB pathways and improves therapeutic outcome in experimental colitis , 2018, Drug Delivery and Translational Research.
[21] Marcus Groettrup,et al. Prevention of neuronal apoptosis by astrocytes through thiol-mediated stress response modulation and accelerated recovery from proteotoxic stress , 2018, Cell Death & Differentiation.
[22] M. Núñez,et al. New Perspectives in Iron Chelation Therapy for the Treatment of Neurodegenerative Diseases , 2018, Pharmaceuticals.
[23] K. Wimalasena,et al. Characteristics of the mitochondrial and cellular uptake of MPP+, as probed by the fluorescent mimic, 4'I-MPP+ , 2018, bioRxiv.
[24] M. Núñez,et al. Development of an iron-selective antioxidant probe with protective effects on neuronal function , 2017, PloS one.
[25] E. Isachenko,et al. Use of the fluorescent dye tetramethylrhodamine methyl ester perchlorate for mitochondrial membrane potential assessment in human spermatozoa , 2017, Andrologia.
[26] S. Sollott,et al. Mitochondrial membrane potential. , 2017, Analytical biochemistry.
[27] Anthony R. White,et al. Nexus between mitochondrial function, iron, copper and glutathione in Parkinson's disease , 2017, Neurochemistry International.
[28] YongKeun Park,et al. Measurements of morphological and biophysical alterations in individual neuron cells associated with early neurotoxic effects in Parkinson's disease , 2017, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[29] F. Heredia,et al. Cyclic voltammetry to evaluate the antioxidant potential in winemaking by-products. , 2017, Talanta.
[30] F. Torti,et al. Mitochondria and Iron: current questions , 2017, Expert review of hematology.
[31] Simon C Watkins,et al. Live imaging of mitochondrial dynamics in CNS dopaminergic neurons in vivo demonstrates early reversal of mitochondrial transport following MPP+ exposure , 2016, Neurobiology of Disease.
[32] C. Pourzand,et al. A Powerful Mitochondria-Targeted Iron Chelator Affords High Photoprotection against Solar Ultraviolet A Radiation , 2016, The Journal of investigative dermatology.
[33] W. Vilegas,et al. LDH, proliferation curves and cell cycle analysis are the most suitable assays to identify and characterize new phytotherapeutic compounds , 2016, Cytotechnology.
[34] S. Kuo,et al. The epigenetic regulation of HIF-1α by SIRT1 in MPP(+) treated SH-SY5Y cells. , 2016, Biochemical and biophysical research communications.
[35] Kawinthra Khwanraj,et al. Differential Expression of Tyrosine Hydroxylase Protein and Apoptosis-Related Genes in Differentiated and Undifferentiated SH-SY5Y Neuroblastoma Cells Treated with MPP+ , 2015, Neurology research international.
[36] M. Núñez,et al. The novel mitochondrial iron chelator 5-((methylamino)methyl)-8-hydroxyquinoline protects against mitochondrial-induced oxidative damage and neuronal death. , 2015, Biochemical and biophysical research communications.
[37] Marta A. Uzarska,et al. Compartmentalization of iron between mitochondria and the cytosol and its regulation. , 2015, European journal of cell biology.
[38] R. Lill,et al. The role of mitochondria and the CIA machinery in the maturation of cytosolic and nuclear iron-sulfur proteins. , 2015, European journal of cell biology.
[39] M. Núñez,et al. Mitochondrial iron homeostasis and its dysfunctions in neurodegenerative disorders. , 2015, Mitochondrion.
[40] R. Lill,et al. The role of mitochondria in cytosolic-nuclear iron–sulfur protein biogenesis and in cellular iron regulation. , 2014, Current opinion in microbiology.
[41] Pamela J. Shaw,et al. Superoxide dismutase 1 mutation in a cellular model of amyotrophic lateral sclerosis shifts energy generation from oxidative phosphorylation to glycolysis , 2014, Neurobiology of Aging.
[42] B. Głód,et al. Total antioxidant potential assay with cyclic voltammetry and/or differential pulse voltammetry measurements , 2014 .
[43] C. Mawrin,et al. Review: Iron metabolism and the role of iron in neurodegenerative disorders , 2014, Neuropathology and applied neurobiology.
[44] R. Rego,et al. Comparative study of the antioxidant capacity and polyphenol content of Douro wines by chemical and electrochemical methods. , 2013, Food chemistry.
[45] M. Grabolle,et al. Relative and absolute determination of fluorescence quantum yields of transparent samples , 2013, Nature Protocols.
[46] R. Lill,et al. The role of mitochondria in cellular iron-sulfur protein biogenesis: mechanisms, connected processes, and diseases. , 2013, Cold Spring Harbor perspectives in biology.
[47] Marta A. Uzarska,et al. The role of mitochondria in cellular iron-sulfur protein biogenesis and iron metabolism. , 2012, Biochimica et biophysica acta.
[48] T. Schwarz,et al. The pathways of mitophagy for quality control and clearance of mitochondria , 2012, Cell Death and Differentiation.
[49] B. Van Houten,et al. Impaired mitochondrial biogenesis contributes to depletion of functional mitochondria in chronic MPP+ toxicity: dual roles for ERK1/2 , 2012, Cell Death and Disease.
[50] T. Rouault. Biogenesis of iron-sulfur clusters in mammalian cells: new insights and relevance to human disease , 2012, Disease Models & Mechanisms.
[51] M. Ashcroft,et al. HIF-1α localization with mitochondria , 2011, Cell cycle.
[52] M. Das,et al. Generation of reactive oxygen species in 1-methyl-4-phenylpyridinium (MPP+) treated dopaminergic neurons occurs as an NADPH oxidase-dependent two-wave cascade , 2011, Journal of Neuroinflammation.
[53] G. Semenza. Hypoxia-inducible factor 1: regulator of mitochondrial metabolism and mediator of ischemic preconditioning. , 2011, Biochimica et biophysica acta.
[54] D. Hauchard,et al. Total phenolic contents, radical scavenging and cyclic voltammetry of seaweeds from Brittany , 2011 .
[55] K. O’Malley,et al. The Parkinsonian Mimetic, MPP+, Specifically Impairs Mitochondrial Transport in Dopamine Axons , 2011, The Journal of Neuroscience.
[56] M. Núñez,et al. Iron mediates neuritic tree collapse in mesencephalic neurons treated with 1-methyl-4-phenylpyridinium (MPP+) , 2011, Journal of Neural Transmission.
[57] S. Perry,et al. Mitochondrial membrane potential probes and the proton gradient: a practical usage guide. , 2011, BioTechniques.
[58] K. Chan,et al. Mitochondrial UCP5 is neuroprotective by preserving mitochondrial membrane potential, ATP levels, and reducing oxidative stress in MPP+ and dopamine toxicity. , 2010, Free radical biology & medicine.
[59] J. Andersen,et al. Chronic expression of H-ferritin in dopaminergic midbrain neurons results in an age-related expansion of the labile iron pool and subsequent neurodegeneration: implications for Parkinson's disease , 2009, Brain Research.
[60] E. Gnaiger. Capacity of oxidative phosphorylation in human skeletal muscle: new perspectives of mitochondrial physiology. , 2009, The international journal of biochemistry & cell biology.
[61] L. Cantley,et al. Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.
[62] S. Vatner,et al. Downregulation of MiR-199a Derepresses Hypoxia-Inducible Factor-1α and Sirtuin 1 and Recapitulates Hypoxia Preconditioning in Cardiac Myocytes , 2009, Circulation research.
[63] E. Gnaiger. Polarographic Oxygen Sensors, the Oxygraph, and High‐Resolution Respirometry to Assess Mitochondrial Function , 2008 .
[64] M. Rathbone,et al. MPP+-induced cytotoxicity in neuroblastoma cells: Antagonism and reversal by guanosine , 2007, Purinergic Signalling.
[65] M. Elstner,et al. Individual dopaminergic neurons show raised iron levels in Parkinson disease , 2007, Neurology.
[66] Maya Shvartsman,et al. Intracellular labile iron pools as direct targets of iron chelators: a fluorescence study of chelator action in living cells. , 2005, Blood.
[67] F. Sun,et al. Melatonin protects against MPTP/MPP+‐induced mitochondrial DNA oxidative damage in vivo and in vitro , 2005, Journal of pineal research.
[68] D. Richardson,et al. Iron trafficking in the mitochondrion: novel pathways revealed by disease. , 2005, Blood.
[69] A. M. Brett,et al. Electrochemical Oxidation of Quercetin , 2003 .
[70] F. Petrat,et al. Selective determination of mitochondrial chelatable iron in viable cells with a new fluorescent sensor. , 2002, The Biochemical journal.
[71] I. Wilson,et al. Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. , 2000, European journal of biochemistry.
[72] A. Graybiel,et al. The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. , 1999, Brain : a journal of neurology.
[73] J C Reed,et al. Mitochondria and apoptosis. , 1998, Science.
[74] M. L. Schmidt,et al. α-Synuclein in Lewy bodies , 1997, Nature.
[75] L. Bruce,et al. Electron microscopic differentiation of directly and transneuronally transported DiI and applications for studies of synaptogenesis , 1997, Journal of Neuroscience Methods.
[76] M. G. Honig,et al. Dil and DiO: versatile fluorescent dyes for neuronal labelling and pathway tracing , 1989, Trends in Neurosciences.
[77] C. Marsden,et al. Increased Nigral Iron Content and Alterations in Other Metal Ions Occurring in Brain in Parkinson's Disease , 1989, Journal of neurochemistry.
[78] C. Marsden,et al. INCREASED NIGRAL IRON CONTENT IN POSTMORTEM PARKINSONIAN BRAIN , 1987, The Lancet.
[79] W. Nicklas,et al. Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. , 1985, Life sciences.
[80] J. Langston,et al. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. , 1983, Science.
[81] F. Fornai,et al. MPTP Neurotoxicity: Actions, Mechanisms, and Animal Modeling of Parkinson’s Disease , 2021, Handbook of Neurotoxicity.
[82] M. Teitell,et al. Techniques to monitor glycolysis. , 2014, Methods in Enzymology.
[83] D. Lee,et al. Astaxanthin protects against MPTP/MPP+-induced mitochondrial dysfunction and ROS production in vivo and in vitro. , 2011, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[84] U. Walter. Transcranial sonography in brain disorders with trace metal accumulation. , 2010, International review of neurobiology.
[85] Dean P. Jones,et al. Divergent mechanisms of paraquat, MPP+, and rotenone toxicity: oxidation of thioredoxin and caspase-3 activation. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.
[86] Simon C Watkins,et al. Regulation of autophagy by extracellular signal-regulated protein kinases during 1-methyl-4-phenylpyridinium-induced cell death. , 2007, The American journal of pathology.
[87] C. Gabriel,et al. Effect of 1-methyl-4-phenylpyridinium (MPP+) on mitochondrial membrane potential in cerebellar neurons: Interaction with the NMDA receptor , 2005, Journal of Neural Transmission.
[88] M G Spillantini,et al. Alpha-synuclein in Lewy bodies. , 1997, Nature.
[89] K. Suzuki,et al. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-like compounds on mitochondrial respiration. , 1990, Advances in neurology.